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Abstract
Background: Depression is one of the most common reasons for consulting in primary care.
Acupuncture is a popular complementary therapy choice for depression but its evidence base is
poor with more robust high quality trials being required. More than half of depressed patients
experience painful symptoms, with severe pain being associated with poor response to
antidepressants. Acupuncture may have much to offer as an intervention for depression that also
helps alleviate pain. Non-directive counselling is the most widely used psychological approach for
depression in NHS settings, and provides a useful pragmatic comparison for acupuncture that
would, according to our pre-trial qualitative research, be of high interest to doctors and patients.
Methods and design: The pilot study uses five arms and involves a pragmatic design. All patients
will continue to receive usual care. Four groups of patients will be allocated to acupuncture, or non-
directive counselling, in addition to usual GP care. The acupuncture and counselling arms will be
further split into two groups to explore different treatment regimens. The primary outcome
measure is the BDI II. Potentially eligible patients will be screened for depression using the PHQ-
9, which is also a secondary outcome measure. Other secondary measures include the SF 36 bodily
pain subscale, the CORE OM, the WBQ-12 and the EQ5D. Health economic data will be collected
and measures of therapeutic engagement will be used to compare patient's views of therapists and
GPs. The study will employ a fully randomised preference design with collection of data on patient
preferences and prior expectations.
Discussion: This study has been implemented, and data are currently being analysed to inform the
design of a full scale trial. Two practical operational issues that impacted on study implementation
are discussed. Firstly, the challenge of recruiting depressed patients via GP consultation. Secondly,
the problem of poor uptake and high attrition for counselling and acupuncture, which appeared to
be associated with poor questionnaire return, and resulted in missing data. These problems may
be relevant to other researchers working in the area of depression, or similar illnesses, where
patients may lack motivation and energy to engage in research, or attend for treatment.
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Background
Need for a trial
Depression is one of the most common reasons for con-
sulting in primary care [1]. The economic burden of this
health problem in the UK is estimated to be £9 billion per
annum with £370 million being due to direct costs of
treatment [2]. Despite these considerable costs, current
pharmacological and psychological interventions options
have limited acceptability and effectiveness. A recent sur-
vey of London GPs found an "effectiveness gap" in the
treatment of depression, an effectiveness gap being
defined as an area of clinical practice in which GPs consid-
ered available treatments as not fully effective [3]. Up to
33% of patients do not show an adequate response to
pharmacological antidepressant treatment [4], and 30%
do not adhere to their medication regime [1]. Patients
have expressed the view that there is an over-reliance on
prescribed antidepressant medications and that they are
keen to have a range of possible treatment choices [5].
A significant number of individuals who are diagnosed
and treated for depression also present with painful symp-
toms, with prevalence estimates ranging from 43% to
65% [6]. A recent survey of 644 respondents conducted by
the Depression Alliance found that 99% of people with
depression have physical symptoms and 85% believe
their "quality of life could be greatly improved if their
aches and pains were managed effectively" [7]. GPs are
optimally placed to manage these patients with both
painful conditions and depression, but feel ill equipped
to do so [6]. Patients with multiple painful symptoms and
depression are less satisfied with their medical care than
patients without mental disorders [8]. Evidence suggests
that the presence of pain, particularly if it is severe, may be
associated with a poor response to SSRIs [9].
Previous research on the main complementary therapies
in the UK has shown that acupuncture is one of the most
commonly used CAM (Complementary and Alternative
Medicine) modalities in the UK [10], and that depression
is regularly treated by acupuncturists [11]. Recent system-
atic reviews of acupuncture for depression, including one
from the Cochrane Collaboration which included seven
randomised controlled trials, have concluded that the sci-
entific rigour of studies to date has been too poor to ena-
ble robust conclusions to be drawn about the effectiveness
of the intervention [12,13]. Reasons for poor methodo-
logical quality included: inadequate sample sizes; inade-
quate reporting; poorly defined outcome criteria;
assessors not blinded; and lack of follow-up or longer
term outcomes including relapse prevention. Neverthe-
less, the evidence "generated promising results" [12] and
further research is "required" [13]. None of the studies
identified by the reviews was conducted in the UK, and in
the majority of the trials the acupuncture intervention did
not reflect the sort of treatment a person would be likely
to receive from a member of the British Acupuncture
Council, the leading professional body for acupuncturists
in the UK. It is in this context that we set out this proposal
for further research to develop a platform for the evalua-
tion of depression, leading to research that will support
health care decision makers and patients themselves in
making appropriate choices.
The acupuncture intervention, and selection of a suitable 
comparator arm
Pre- pilot qualitative research suggested that acupuncture
should be provided in addition to usual GP care and that
stakeholders (GPs, patients and acupuncture practition-
ers) would be most interested in a pragmatic trial where
the acupuncture intervention would reflect normal clini-
cal practice, and be compared with an existing interven-
tion such as antidepressants, or psychological therapy. Of
these choices non-directive counselling was the most
practically feasible comparator arm for acupuncture. Non-
directive, or 'person centred' counselling as it is also
known as, is, according to the CORE database, the
approach that is most often used for depressed patients in
UK NHS settings in comparison with psychoanalytic or
cognitive behavioural methods [14] although it has
received considerably less research attention than the lat-
ter [15,16]. Non-directive counselling also provides a use-
ful comparison to acupuncture because both therapies
involve a similar level of contact time and attention
between practitioner or therapist and patient, and a posi-
tive therapeutic alliance is thought to be key to both types
of intervention. This means the trial can be partially
explanatory. However, counselling can only be an approx-
imate time and attention control for acupuncture because
both therapies are complex interventions, underpinned
by a different theoretical rationale and with expected spe-
cific effects.
The acupuncture intervention arm was developed through
consulting with over 30 practitioners formally and infor-
mally. Quantitative and qualitative research methods
were used, the results of which were used to develop a
study practitioner's log. This log set out expected treat-
ment parameters and facilitated reporting according to
STRICTA guidelines [17].
The counselling intervention was developed through con-
sultation with trial counsellors, who outlined the param-
eters of the therapy they would provide to trial patients in
a written document or 'manual'.
Study aims and objectives
Aims
To conduct a pilot for a randomised controlled trial that
will evaluate the effectiveness and cost-effectiveness ofTrials 2009, 10:3 http://www.trialsjournal.com/content/10/1/3
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acupuncture for management of an acute episode of
depression and the longer term relapse rates, when pro-
vided as adjunct to usual GP care.
To pilot an evaluation of acupuncture versus non-direc-
tive counselling that explores pain as a co-variable and
investigates other factors that may impact on outcomes,
including compliance and acceptability of acupuncture
and non directive counselling; personal history of depres-
sion; severity of depression; patient preferences; prior
expectations; and quantitative indicators of a positive
therapeutic relationship (working alliance, enablement
and empathy).
Objectives
In this pilot study our main objectives are:
To estimate the sample size for the full-scale trial based on
the variability in the primary outcome measure and likely
loss to follow up.
To evaluate recruitment procedures and establish poten-
tial recruitment rates.
To explore treatment attendance patterns, potential opti-
mal treatment regimens, and acceptability of treatment
protocols to practitioners.
To assess the acceptability and adequacy of trial question-
naires.
To establish a system for monitoring adverse events that is
adequate and appropriate.
Methods
The design is a pilot pragmatic randomised controlled
trial of acupuncture for patients in primary care who are
suffering from depression with participants being allo-
cated to one of three main intervention arms. Patients
allocated to either acupuncture or non directive counsel-
ling will be further split into two groups each receiving up
to a maximum of either 12 or 24 sessions in order to
explore optimal treatment regimens for recovery and
relapse prevention. A pilot trial is according to MRC
guidelines for the evaluation of complex health care inter-
ventions the ideal time to investigate issues such as dosage
levels [18].
1. Usual GP care
2. Usual GP care plus traditional acupuncture, practised in
accordance with Chinese medical theories, and delivered
by acupuncturists who are members of the British Acu-
puncture Council who have been qualified for at least
three years. Fifty percent of acupuncture patients will be
offered up to 12 sessions to be delivered over a three
month period. The remaining fifty percent will be offered
12 sessions in the first three months followed by a further
12 sessions to be delivered over the following/remaining
six months of the study.
Usual care plus non-directive counselling
Patients will be offered counselling in a similar way to
acupuncture, i.e. fifty percent will have up to 12 sessions
over a three month period and fifty percent will receive up
to a further 12 sessions during the remainder of the follow
up period (six months).
We will collect data on all treatments provided in all five
arms of the trial.
Randomisation
Patients will be allocated randomly, by the York Trials
Unit, to one of the five groups described above. Research-
ers and clinicians will have no influence on the allocation
of patients.
Eligibility
Inclusion criteria
Patients who are being managed in primary care who have
consulted their GP and have been diagnosed with depres-
sion, with a depression score of 10 or above on the PHQ-
9 (Patient Health Questionnaire 9) [19], a Diagnostic Sta-
tistical Manual IV based screening instrument for depres-
sion, and who are over eighteen years of age.
Exclusion criteria
Those who have been diagnosed with terminal illness.
Those with mobility issues who cannot travel to appoint-
ments.
Those involved with other research projects.
Those with dementia, learning difficulties, and communi-
cation problems.
Those currently receiving acupuncture or counselling.
Those who cannot speak sufficient English to communi-
cate with a counsellor or acupuncture practitioner.
Those with alcohol or substance abuse problems.
Those who have received a diagnosis of bipolar disorder,
psychosis, or personality disorder.
We will be able to check the patients medical records for
all of the above except whether they are receiving acu-
puncture or counselling, participating in other researchTrials 2009, 10:3 http://www.trialsjournal.com/content/10/1/3
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and their level of English. We will screen for these in the
baseline questionnaire.
Outcome measures
Primary
BDI (Beck Depression Inventory) [20].
Secondary
PHQ-9, CORE 34 [21], SF-36 Bodily Pain [22], EQ5D,
and the W-BQ12 (Well-Being Questionnaire) [23]. Out-
come measures will be collected by postal questionnaire
at three, six, and nine months.
Quantitative process measures at three months will
include the PEI (Patient Enablement Instrument) and the
CARE (Consultational & Relational Empathy) Measure
(CARE) [24,25], the WAI (Working Alliance Inventory-
12) [26] as well as measures of satisfaction and adverse
events. Participants who are allocated to acupuncturing
and counselling interventions will receive additional
monitoring in order to evaluate key therapeutic processes
(empathy, enablement and working alliance) and assess
optimal duration of treatment. The following instruments
will be used: the PEI after first and final consultation, and
monthly; the CARE measure, after first and final consulta-
tion; and the WAI at one month (wording to be modified
for acupuncture patients; "therapist" will be substituted
with "practitioner" and "therapy" with "treatment"). All
adverse events will be continuously monitored by acu-
puncturists and counsellors, and all adverse events will be
collected at three, six and twelve months. Trial question-
naires will collect information about significant life-
events at three, six and twelve months. Although such
events might be expected to occur randomly a major set-
back in life might conceivably negate the positive impact
of any form of therapy or intervention and should be
recorded.
Sample size
One of the main objectives of the study is to provide an
estimate of the sample size required for the full-scale trial.
We plan to recruit forty people into this pilot study.
Twelve will receive up to 12 sessions of acupuncture as an
adjunct to usual care, with six receiving up to 12 further
treatments. Twelve will receive counselling as an adjunct
to usual care, with six receiving up to a further 12 sessions.
Sixteen will continue to receive usual GP care.
Recruitment
We will pilot two methods of recruitment and evaluate
related recruitment procedures and rates. Firstly we will
use a database recruitment method to recruit those who
have already been diagnosed with depression and are still
depressed (prevalent cases). These potential participants,
who will have received a diagnosis of depression within
the previous three years, will be identified from GP data-
bases. Their GPs will send a covering letter informing
them about the study, a Participant Information Leaflet,
Consent Forms, and Baseline Questionnaire. Based on
preliminary searches through a GP database, we estimate
that three general practice surgeries in the Selby and York
PCT will be sufficient to recruit in full.
Secondly, GPs and mental-health workers within partici-
pating practices will refer newly diagnosed (incident)
cases of depression, either those with a first episode or a
recurrence, into the study. GPs will give eligible individu-
als a Patient Information Leaflet, Consent Forms and
Baseline Questionnaire, and letter inviting them to con-
sider participating in this study.
Analysis
Our primary analysis will be to determine the sample size
for the full-scale trial. We will conduct an exploratory
analysis on an intention-to-treat basis, using analysis of
covariance (ANCOVA), which incorporates an adjustment
for differences between groups at baseline.
Cost-effectiveness
We will pilot an economic evaluation from both an NHS
and societal perspective. Data will be collected retrospec-
tively at 3, 6 and 12 months on resource use both within
and outside the NHS, including those costs related to all
contacts with primary and secondary healthcare services,
all contacts with acupuncture practitioners, and counsel-
lors, prescribed and over-the-counter medication, herbs
and remedies, private sector health services and any addi-
tional complementary therapies. For the pilot, it will be
important to determine the key cost drivers, so that we can
ensure that this data is accurately collected in the full-scale
trial.
NHS cost implications
The GP practices will be involved in helping with the data-
base recruitment. This will involve each practice manager
in two to three hours work per practice.
Trial Management
The Trial Team
The trial team includes Dr Hugh MacPherson (Chief
Investigator), Sylvia Schroer (Principle Investigator), Dr
Joy Adamson, Dr Simon Gilbody, GP Principal Dr David
Geddes, and Professor Trevor Sheldon. We will involve
users where possible through York & District Mind,
Depression Alliance, and/or INVOLVE.
Ethical approval was granted for the study in October
2006 by York Local Ethics Committee with further
amendments to questionnaires and information for
patients being approved on 4th Jan 2007 (ref: 06/Q1108/Trials 2009, 10:3 http://www.trialsjournal.com/content/10/1/3
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56). Originally it was planned to conduct a nested quali-
tative study to explore patient's beliefs, explanatory mod-
els of depression, and expectations of treatment however
we decided to pilot quantitative measures instead. The use
of these instruments constituted a protocol amendment
which required approval.
Discussion
Our aim was to conduct a pilot study for a full scale trial
of acupuncture for depression, and to look at its potential
effectiveness in terms of depression recovery and preven-
tion of future episodes. We sought to investigate the feasi-
bility of comparing acupuncture with non-directive
counselling, a widely used primary care intervention, with
both therapies being adjuncts to usual GP care. Recruit-
ment began at the end of January 2007. Randomisation
took place at the end of February 2007. Data collection
was completed at the end of 2007. A CONSORT study
flow diagram [27,28] shows recruitment, uptake of inter-
ventions and loss to follow up (see Figure 1). Study data
are currently being analysed and will be used to inform
the design of a full scale trial.
The discussion below focuses on practical and operational
concerns involved in performing the study, in particular
the problems associated with recruiting depressed
patients into trials via their GP, and also concerns about
poor uptake and attendance rates for psychological inter-
ventions amongst this patient population. These prob-
lems may be of interest to other researchers working in the
area of depression, or other illnesses, where GPs feel pro-
tective of their patients who may also, as a result of their
condition, lack motivation and energy to engage in
research or have problems complying with interventions.
The problem of recruiting patients with depression into 
trials via the GP
GP referrals into depression trials of conventional medical
interventions can be problematic. Reasons for poor refer-
ral have been investigated by Mason et al, with four
themes identified by in depth interviews with 41 GPs. The
first was the content and style of depression consultations
the second was the wish to protect the doctor patient rela-
tionship, the third was the "perceived intrusiveness of
introducing research into a complex consultation" and
finally the GP's perceptions about their own lack of skill
and confidence to introduce research [29]. Our own pre-
trial qualitative research suggested that GPs might feel
uncomfortable with referring depressed patients to acu-
puncture because they are not familiar with this interven-
tion in the context of treating depression.
In the event, the use of database recruitment, which cir-
cumvented the need for doctors to discuss the trial with
patients in a consultation, proved an efficient method. We
achieved a recruitment rate of 11% of patients who were
invited to participate consenting to take part, who met
with the study's inclusion criteria. No patients were
recruited by direct referral from any of the fourteen GPs
who participated in the trial.
The problem of 'poor attendance' of acupuncture and 
counselling interventions
Poor compliance and attendance of mental health services
have been identified as a key problem in primary care. For
example, a trial of a brief psychological intervention
found that non attendance for assessment was 26.1% with
only one in five patients referred to the service completing
their sessions [30]. Since we were researching a similar
patient population, we were concerned about the poten-
tial impact of poor uptake and attendance of counselling
or acupuncture interventions on the pilot trial. Our
resource constraints meant the number of participants in
each of the acupuncture and counselling groups
amounted to only six. One further problem with poor
attendance, or noncompliance, is that intention to treat
analysis, the usual method of analysis for randomised
controlled trials, is likely to underestimate treatment
effects for an intervention, unless noncompliance is negli-
gible [31]. Reasons for poor uptake or attendance of inter-
ventions tend not to be random. Attendance patterns for
the different interventions can be seen in the study flow
diagram. Five out of twenty four participants did not
attend any acupuncture or counselling sessions, even
when allocated, in two cases (one each for acupuncture
and counselling), to the interventions that were believed
to potentially be the 'most helpful' for their depression.
Eleven out of twenty four participants attended no ses-
sions at all, or less than 50% of their maximum number
of allocated sessions. Some participants offered reasons
for poor attendance, which included infectious illness,
difficulties finding time to attend, problems arranging
childcare, and needing to prioritise work commitments.
One participant commented that acupuncture had made
her feel worse in terms of depression, and prematurely ter-
minated treatment.
Numerous letters were sent to all participants, and phone
calls made, to explain the importance of returning ques-
tionnaires, regardless of whether interventions had been
used or adhered to. Nevertheless questionnaire return in
this study was poor: 60% of participants did not return all
of the questionnaires for the primary outcome, measured
at three, six and nine months, and nearly 80% of partici-
pants did not return complete data over the nine month
study period. Questionnaire return was especially low
amongst poor attenders, and there was a significant asso-
ciation, using Fisher's Exact test, between attendance and
questionnaire return for the combined three, six and nine
month questionnaires (p value ≤ 0.0001), see Table 1.Trials 2009, 10:3 http://www.trialsjournal.com/content/10/1/3
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Study flow diagram Figure 1
Study flow diagram.Trials 2009, 10:3 http://www.trialsjournal.com/content/10/1/3
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However, we did not find such an association when we
looked at questionnaire return for all of the nine months
of questionnaires. This might be attributed to the fact that
only 9 out of 40 participants had returned all these ques-
tionnaires.
It may be that we expected too much of our participants,
who were after all suffering with depression, an illness
that can impact severely on motivation and energy levels.
Both acupuncture and counselling can be demanding
interventions in terms of the time and effort that is needed
to attend sessions. In the full scale trial statistical methods
may be used to estimate the clinical effectiveness of inter-
ventions, and account for poor attendance or noncompli-
ance [31,32]. This is important if the results of the trial are
to address the concerns of patients, doctors, and therapists
who are more likely to want to know whether the inter-
vention itself is potentially effective, than allocation to the
intervention.
We had believed, on the basis of piloting experience of
researching the potential benefits of acupuncture for other
health conditions (irritable bowel syndrome, neck pain,
and osteoarthritis of the knee), that postal questionnaires
would be a suitable method of data collection for this
trial. The poor response rates have suggested otherwise
and we will need to rethink data collection for the full
scale trial. It seems likely that this patient group may need
additional support from researchers to help them engage
more fully with the research process, particularly if moni-
toring of trial patients continues for a sufficient period of
time to investigate depression relapse as well as recovery
from a specific episode.
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Table 1: Attendance and questionnaire return
Questionnaire return
Incomplete for all nine 
months
Complete for all nine 
months
Incomplete for 3, 6, and 
9 months
Complete for 3, 6, and 
9 months
Poor Attendance, 
attended less than 50% 
of sessions (n = 11)
11 (35.5%) 0 (0%) 11 (47.8%) 0 (0%)
Good Attendance, 
attended 50% or more 
of sessions (n = 13)
9 (29.0%) 4 (44.4%) 3 (13%) 10 (58.8%)
Usual Care 11 (35.5%) 5 (55.6%) 9 (39.1%) 7 (41.2%)
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